Graham P Collins (Graham Collins)
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 5
Publications (10 Years): 5
University of Oxford Department of Oncology
Affiliation History
University of Oxford Department of Oncology
United Kingdom
Clinical lead for the Oncology Clinical Trials Office
NHS England
United Kingdom
Clinical Expert on the National CAR-T cell panel for Diffuse Large B-cell Lymphoma
Oxford University Hospitals NHS Foundation Trust
United Kingdom
Consultant haematologist and lymphoma lead :: Clinical Haematology
Publications
- Mark J Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins, Hendrick-Tobias Arkenau, Sven de Vos, Barret R B Nuttall, Melih Acar, Kathleen Burke, Rafael D White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David F Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla, Ian W Flinn
- Peter A Henriksen, Peter S Hall, Iain R J Macpherson, Shruti S Joshi, Trisha Singh, Morag Maclean, Stephanie Lewis, Aryelly Rodriguez, Alexander J Fletcher, Russell J Everett, Harriet Stavert, Angus Broom, Lois Eddie, Lorraine Primrose, Heather McVicars, Pamela McKay, Annabel Borley, Clare Rowntree, Simon R Lord, Graham P Collins, John Radford, Amy Guppy, Michelle Claire Williams, Alan Japp, John R Payne, David E Newby, Nicholas L Mills, Olga Oikonomidou, Ninian N Lang
- Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, Luisa Verga, Federico Itri, Zdeněk Ráčil, Julio Dávila-Valls, Sonia Martín-Pérez, Jaap Van Doesum, Francesco Passamonti, Ghaith Abu-Zeinah, Francesca Farina, Alberto López-García, Giulia Dragonetti, Chiara Cattaneo, Maria Gomes Da Silva, Yavuz M Bilgin, Pavel Žák, Verena Petzer, Andreas Glenthøj, Ildefonso Espigado, Caterina Buquicchio, Valentina Bonuomo, Lucia Prezioso, Stef Meers, Rafael Duarte, Rui Bergantim, Ozren Jaksic, Natasha Čolović, Ola Blennow, Martin Cernan, Martin Schönlein, Michail Samarkos, Maria Enza Mitra, Gabriele Magliano, Johan Maertens, Marie-Pierre Ledoux, Moraima Jiménez, Fatih Demirkan, Graham P Collins, Alba Cabirta, Stefanie K Gräfe, Anna Nordlander, Dominik Wolf, Elena Arellano, Raul Cordoba, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Raquel Nunes Rodrigues, Giulia Limberti, Francesco Marchesi, Oliver A Cornely, Livio Pagano
- Alexandros Rampotas, Gavinda Sangha, Graham P Collins
- Adam Gibb, Sarah J Pirrie, Kim M Linton, Victoria Warbey, Kathryn Paterson, Andrew John Davies, Graham P Collins, Tobias Menne, Pamela McKay, Paul A Fields, Fiona M Miall, Eszter Nagy, Keith Wheatley, Rachel Reed, Ivona Baricevic-Jones, Sally F Barrington, John RadfordResults of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY). British journal of haematology 193 (1) (2020)